EQS-News: SYNBIOTIC SE / Key word(s): Investment Trend-setting decontamination: SYNBIOTIC and GOC NEXUS set the gold standard for cannabis 18.12.2024 / 13:06 CET/CEST The issuer
Original-Research: SYNBIOTIC SE – from NuWays AG 18.12.2024 / 09:00 CET/CESTDissemination of a Research, transmitted by EQS News – a service of EQS Group AG.The
EQS-News: Marinomed Biotech AG / Key word(s): Restructure of Company/Insolvency Marinomed Biotech AG: Requirements for successful completion of the restructuring proceedings achieved 17.12.2024 / 13:00
Original-Research: M1 Kliniken AG – from First Berlin Equity Research GmbH 17.12.2024 / 12:00 CET/CESTDissemination of a Research, transmitted by EQS News – a service
EQS-News: EsoCap AG / Key word(s): Scientific publication EsoCap announces publication of comprehensive Phase II results demonstrating ESO-101’s effectiveness in eosinophilic esophagitis 17.12.2024 / 11:00
EQS-News: invIOs GmbH / Key word(s): Conference invIOs to present progress across oncology pipeline during JP Morgan Week 2025 16.12.2024 / 15:00 CET/CEST The issuer
EQS-News: Gerresheimer AG / Key word(s): Miscellaneous/Regulatory Admission Gerresheimer: FDA grants Tentative Approval of SQ Innovation’s Lasix® ONYU* 16.12.2024 / 09:00 CET/CEST The issuer is
EQS-News: Cheplapharm AG / Key word(s): Mergers & Acquisitions CHEPLAPHARM acquires Gemzar from Lilly 16.12.2024 / 08:48 CET/CEST The issuer is solely responsible for the
PolyPeptide Group / Key word(s): Miscellaneous Large-scale SPPS capacity in Braine-l’Alleud starts production 16.12.2024 / 07:00 CET/CEST Media release Large-scale SPPS capacity in Braine-l’Alleud starts
Xlife Sciences AG / Key word(s): IPO/Market launch 16-Dec-2024 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer